• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Naloxone Hydrochloride Injection

Audience: Hospital pharmacists, anesthesia providers and other healthcare professionals

Health care professionals are notified of a shortage of Naloxone HCl injection, a narcotic antagonist. This appears to be a temporary situation of two to three months in length. FDA has identified a temporary alternate supplier of Naloxone Hydrochloride Injection, USP in 0.4 mg/mL ampoules (1mL) and vials (10mL), as well as 1 mg/mL vials (2mL) effective April 4, 2001. Physicians and hospitals will be able to obtain this product via overnight delivery. This temporary program will not cover the pediatric strength of product (0.02 mg/mL). Supplies of this strength are available, but limited. FDA will continue to monitor this important health issue until its resolution. Updates on this product and further information on the FDA Drug Shortage program can be found at 
www.fda.gov/cder/drug/shortages.

[April 6, 2001 - Drug Shortage Alert - FDA]